User:Mr. Ibrahem/Pomalidomide

Pomalidomide, sold under the brand name Pomalyst and Imnovid, is a medication used to treat multiple myeloma (MM) and Kaposi sarcoma (KS). For MM it is used when other treatments have failed. For KS it is used when HAART is not affected or in those who are HIV negative. It is taken by mouth.

Common side effects include tiredness, low neutrophils, low red blood cells, nausea, diarrhea, shortness of breath, fever, and low platelets. Other side effects may include liver problems, tumor lysis syndrome, blood clots, and anaphylaxis. Use in pregnancy may harm the baby. It is similar to thalidomide and works by altering the immune system.

Pomalidomide was approved for medical use in the United States and Europe in 2013. In the United Kingdom 4 weeks of treatment costs the NHS about £8,900 as of 2021. In the United States this amount costs about 20,000 USD.